I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 3 studies | 34% ± 9% | |
| glutamatergic neuron | 3 studies | 33% ± 12% | |
| oligodendrocyte | 3 studies | 27% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 3 studies | 34% ± 9% | |
| glutamatergic neuron | 3 studies | 33% ± 12% | |
| oligodendrocyte | 3 studies | 27% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 37% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 413.12 | 1444 / 1445 | 100% | 4.99 | 183 / 183 |
| brain | 98% | 284.06 | 2593 / 2642 | 100% | 5.35 | 705 / 705 |
| lung | 100% | 470.38 | 578 / 578 | 97% | 3.15 | 1126 / 1155 |
| breast | 100% | 438.10 | 459 / 459 | 97% | 4.80 | 1089 / 1118 |
| pancreas | 99% | 229.74 | 325 / 328 | 97% | 2.71 | 173 / 178 |
| stomach | 100% | 304.00 | 358 / 359 | 96% | 3.64 | 275 / 286 |
| thymus | 100% | 562.62 | 653 / 653 | 96% | 2.96 | 579 / 605 |
| intestine | 100% | 501.20 | 966 / 966 | 96% | 2.85 | 504 / 527 |
| uterus | 100% | 580.13 | 170 / 170 | 94% | 3.01 | 433 / 459 |
| kidney | 100% | 341.52 | 89 / 89 | 94% | 3.29 | 847 / 901 |
| skin | 100% | 518.54 | 1806 / 1809 | 93% | 3.36 | 438 / 472 |
| adrenal gland | 100% | 378.72 | 258 / 258 | 91% | 3.05 | 210 / 230 |
| bladder | 100% | 465.14 | 21 / 21 | 91% | 2.77 | 460 / 504 |
| ovary | 100% | 552.83 | 180 / 180 | 90% | 2.45 | 388 / 430 |
| prostate | 100% | 492.62 | 245 / 245 | 87% | 1.97 | 436 / 502 |
| liver | 98% | 193.33 | 222 / 226 | 38% | 0.69 | 155 / 406 |
| spleen | 100% | 468.89 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.32 | 1 / 1 |
| blood vessel | 100% | 393.81 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 403.63 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 99% | 266.40 | 798 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 3.46 | 44 / 45 |
| heart | 97% | 372.04 | 838 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 3.42 | 28 / 29 |
| peripheral blood | 91% | 300.49 | 847 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 65% | 1.43 | 52 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF81 |
| Protein name | Alternative protein ZNF81 Zinc finger protein 81 Zinc finger protein 81 (HFZ20) |
| Synonyms | |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | ENST00000338637.13 ENST00000376954.6 B1AJV1 B1AJV2 ENST00000376950.4 ENST00000334937.8 L8E7Y0 P51508 |
